Redundant pathways for removal of defective RNA polymerase II complexes at a promoter-proximal pause checkpoint

Area of Science:

• Molecular Biology
• Gene Expression Regulation
• Cellular Checkpoints

Background:

• The precise biological roles of the Integrator complex and RNA polymerase II (RNAPII) promoter-proximal pausing are not fully understood.
• Investigating these processes is crucial for comprehending gene expression fidelity and cellular health.

Purpose of the Study:

• To elucidate the function of INTS6 within the Integrator complex in regulating RNAPII transcription.
• To identify the molecular mechanisms that control RNAPII activity at promoter-proximal pause sites.
• To understand the interplay between transcription factors and degradation machinery in maintaining genomic integrity.

Main Methods:

• Human cell culture and genetic manipulation (e.g., INTS6 loss-of-function).
• Co-immunoprecipitation assays to study protein-protein interactions.
• Western blotting to detect protein ubiquitylation and degradation.
• Analysis of nascent RNA transcripts (e.g., capping status).

Main Results:

• Loss of INTS6 increases RNAPII interactions with CRL3^ARMC5 E3 ligase, leading to ubiquitylation and degradation of RPB1.
• This ARMC5-dependent degradation is triggered by defects in Integrator, DSIF, and capping enzyme.
• Compromising both Integrator and CRL3^ARMC5 pathways halts cell growth and causes RNAPII dispersal.
• ARMC5 knockout cells exhibit increased production of uncapped transcripts.

Conclusions:

• CRL3^ARMC5 acts as a critical checkpoint, collaborating with Integrator to eliminate aberrant RNAPII complexes at promoter-proximal pause sites.
• This checkpoint mechanism is essential for maintaining the integrity of RNAPII transcription.
• Dysregulation of this pathway can lead to cell growth arrest and potentially contribute to disease states.